-
effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/hypofractionated-radiation-therapy-protocol.pdf
April 17, 2024 - Five-year survival rates range from 100% for men with local disease at
diagnosis to 35.4% for men with … sufficient data are available, we will use standardization frameworks such as the Template for
Intervention Description … Fifteen-Year Outcomes after Monitoring, Surgery, or
Radiotherapy for Prostate Cancer. … Better reporting of interventions: template for intervention
description and replication (TIDieR) checklist … to previous versions; and a table with the date of each amendment, which will be
accompanied by a description
-
effectivehealthcare-admin.ahrq.gov/products/child-growth-development-outcomes/protocol
November 01, 2024 - cow milk, regardless of milk fat content, should not be included in an infant’s diet until after 1 year … Microsoft Excel® for data extraction for each Key Question that includes study characteristics (e.g., author … , year of publication and data collection, country, study design, inclusion and exclusion criteria), … Criteria for assessing the risk of bias of individual studies 51 Rating Description and Criteria Low … Description of the strength of evidence grades Strength of Evidence Description High Very confident that
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/children-special-needs-transition_disposition-comments.pdf
June 17, 2014 - large number of the 500,000 youth with special health
care needs who transition to adult care each year … We have added a description of outcomes
to the Background section. … Peer Reviewer
1 Methods
The author do not specific the procedure that was employed to access the grey … We have added information to
the methods description to make this
clearer. … We have added information to
the methods description to make this
clearer.
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/gout-diagnosis-disposition-160727.pdf
February 24, 2016 - Co-Author Dr. Fitzgerald may be a
resource for this. … We have replaced the word
"accepted" with "validated," although we are
not sure this description is … Space is limited in the abstract and didn't
permit a full description. … The AHRQ systematic review report format
specifies we begin the Results section with a
description … We have clarified it in the
description, which we moved down in that
section.
-
effectivehealthcare-admin.ahrq.gov/products/glaucoma-screening/research-protocol
December 01, 2019 - with a median age-adjusted prevalence of 4.6% and 1.6% among blacks and whites, respectively (based on year … A detailed description of Food and Drug Administration (FDA) approval status, indications, and warnings … Timing
Outcomes for Key Questions 1, 2, 4, 5, and 6 will be assessed at 1 year of follow-up and at … Amendments
In the event of protocol amendments, the date of each amendment will be accompanied by a description
-
effectivehealthcare-admin.ahrq.gov/products/cesarean-birth-2010/research-protocol
December 01, 2019 - ethnicity, maternal age, and other factors, with the highest rates in the southeastern States. 2 One 2007 author … evidence table may vary by KQ as appropriate, but the tables will contain some common elements, such as author … , year of publication, study location (e.g., country, city, state) and time period, population description … limiting the ability to apply interventions to other populations or other settings, such as inadequate description … Amendments
In the event of protocol amendments, the date of each amendment will be accompanied by a description
-
effectivehealthcare-admin.ahrq.gov/products/phenylketonuria/research-protocol
December 01, 2019 - One comment suggested that "cognitive decline" may not be the most accurate outcome description, so we … evidence table may vary by KQ as is appropriate, but the tables will contain some common elements, such as author … , year of publication, study location (e.g., country, city, state) and time period, population description … limiting the ability to apply interventions to other populations or other settings, such as inadequate description
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/skin-lesions-evaluation_research-protocol.pdf
August 23, 2010 - These two types of nonmelanomatous
(NMSC) lesions, responsible for more than 800,000 cases per year, … .4 One study found that “melanoma incidence
rates had doubled in all socioeconomic groups over a 10-year … period”.5 Another study found that
melanoma incidence rates have increased by 3% per year in white … From qualified studies, we will extract data on the citation (first
author name, journal and year of
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/child-growth-development-outcomes-protocol-amended.pdf
November 18, 2024 - cow milk, regardless of milk fat content, should not be
included in an infant’s diet until after 1 year … Microsoft Excel® for data extraction for each Key
Question that includes study characteristics (e.g., author … , year of publication and data collection,
country, study design, inclusion and exclusion criteria), … Criteria for assessing the risk of bias of individual studies50
Rating Description and Criteria
Low … Description of the strength of evidence grades
Strength of
Evidence
Description
High Very confident
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/treatment-resistant-depression_disposition-comments.pdf
September 01, 2011 - the differentiation into Tiers 1-3 and MMD alone or mixed
groups, I struggled to find a compelling description … Earlier this year, Janicak and
colleagues published the results of a 6-month naturalistic follow-up … Peer Reviewer
#8
General Nemeroff [et al., PNAS, 2003—and Michael Thase was a co-author]
studied … "Two-year outcome of vagus
nerve stimulation in treatment-resistant depression." … "Two-year outcome of vagus
nerve stimulation (VNS) for treatment of major depressive episodes."
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/cer-221-copd-comments_0.pdf
October 11, 2019 - The current qualitative description is sufficient
according to our clinical experts and other peer … Risk trajectories of readmission and death in
the first year after hospitalization for chronic obstructive … Descriptions were presented at the end of study
description for each KQ, pages 13, 22, 42, 45. … Peer reviewer #4 Results Page 42/302: Current description of the Evidence Base is
superficial and does … This comment applies to the
description of evidence base for all key questions.
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/heart-failure-transition-care_disposition-comments.pdf
May 27, 2014 - Patients were included in this trial if
they had any hospitalization within the past year
(and were … According to Table 1
in that study, approximately 15% had no
hospitalization within the past year. … The librarian who assisted with the search and
retrieval of articles is listed as an author in the … Requests on where/how to locate
included articles can be sent to the
corresponding author.
146 Peer … Data from the 2004 Naylor article was obtained
from the author (in the original publication, it
was
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/chronic-cough_disposition-comments.pdf
January 07, 2013 - The
audience of this report is not explicitly stated but assumed based
on the general description of … Peer Reviewer #3 General Description of the studies suggests none was an RCT, but the
table includes … The revised “Description of Included
Studies” section for KQ2 states,
“Thirty-three of the 48 studies … The
report is generally very well-written and is exhaustive in the
description of the approach. … As suggested, we have modified our
description of the control group to
clarify.
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/atypical-antipsychotics-off-label-update_disposition-comments.pdf
September 01, 2011 - Reviewer 1
Discussion /
Conclusion
The report provides a balanced description of the relevant … 64 Table
12
P 80 - Table 12 - later in the text there is explanation as to why AZ is listed as an author … We judged
it is more informative to
list Astra Zeneca as the
author than
"anonymous"
TEP #1 Results … Typical antipsychotics have Tardive dyskinesia rates of 7% per year of exposure, while
atypicals range
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/therapies-for-autism-spectrum-disorder-2-9-2010.pdf
January 01, 2010 - These spreadsheets will allow each author to count
key data points, such as study location, study type … evidence table will
vary by key question, but the tables will contain some common elements, such as author … , year of
publication, study location (e.g., country, city, state) and time period, population description … Autism and Developmental Disabilities Monitoring Network Surveillance Year 2002
Principal Investigators … Amendments
In the event of protocol amendments, the date of each amendment will be accompanied
by a description
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/autism_research-protocol.pdf
December 09, 2009 - These spreadsheets will allow each author to count
key data points, such as study location, study type … evidence table will
vary by key question, but the tables will contain some common elements, such as author … , year of
publication, study location (e.g., country, city, state) and time period, population description … Autism and Developmental Disabilities Monitoring Network Surveillance Year 2002
Principal Investigators … Amendments
In the event of protocol amendments, the date of each amendment will be accompanied
by a description
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/study-design-classification_research.pdf
December 01, 2010 - The findings and conclusions in this document are
those of the author(s), who are responsible for its … Description of study design classification tools rejected for further evaluation................8
Table … Classification of studies: Round 1
Study
(author,
year)
Reference
Standard
NonR
trial RCT … Classification of studies: Round 1 (continued)
Study
(author,
year)
Reference
Standard
NonR … Classification of studies: Round 2
Study
(author,
year)
Reference
Standard
NonR
trial RCT
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/inguinal-hernia_disposition-comments.pdf
August 17, 2012 - Introduction: In the abstract introduction, the sentence "in
children, incidence..." follows right after description … The
experienced surgeon will discredit it because of the major errors
in description of the procedures … We have two
poplulation-based studies in press that suggest that the 770,000
hernia repairs per year … Christine
Chang, AHRQ
Results overall description of studies. … This study was funded by AHRQ and the American College
of Surgeons, and the lead author disclosed financial
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/autism_disposition-comments.pdf
November 01, 2010 - The description of Applied Behavior Analysis (ABA) here is used to
provide a general description of … Methods good description, and sound methods. … For instance,
a study on which I was an author (Howard et al,
2005) is described incorrectly as providing … study measured and
found treatment vs control group differences on at
least outcome (language) a 1 year … individuals participating as peer reviewers and
authors; AHRQ reports typically do not include additional
author
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/osteoarthritis-knee-update-disposition-archived.pdf
May 04, 2017 - It states the searches
commenced with the year 2006 but what
was the end date of the reviews? … We have clarified the
description of self-
management programs in
the PICOTS table. … We have added a description
of our effect estimates in the
Methods section of the main
text under … We
used the same author name
to show it was the same
study but have now changed
it to the Healthy … We included a description of
the limitations of our review.